Abbvie Inc. vs The Cigna Group
ABBV vs CI — side-by-side comparison from reported financials. ABBV leads 6, CI leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
The Cigna Group
CI · Healthcare
$282.43+0.50%Mixed
| Metric | ABBV | CI |
|---|---|---|
| Price | $276.43 | $282.43 |
| Market cap | $488B | $74.6B |
| Revenue (TTM) | $64.4B | $282B |
| Revenue growth | +1.8% | +15.1% |
| Net margin | 9.8% | 2.3% |
| Free cash flow | $18.2B | $10.3B |
| Net cash (debt) | ($56.2B) | ($22.7B) |
| 1-year price return | +19.8% | -7.7% |
| P/E | 77.4 | 11.6 |
| P/E vs own history (cheap-side %) | 23% | 80% |
| Dividend yield | 2.45% | 2.18% |
| Return on equity | 96% | 15% |
| Altman Z-score | 2.33 | 1.77 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 67,700 |
Full résumé-style profiles: ABBV CV · CI CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.